Bixalomer is a non-absorbed, non-calcium, and non-metal phosphate binder indicated for the management of hyperphosphatemia in patients with chronic kidney disease. As a therapeutic agent, it functions… Read more
Bixalomer is a non-absorbed, non-calcium, and non-metal phosphate binder indicated for the management of hyperphosphatemia in patients with chronic kidney disease. As a therapeutic agent, it functions by binding dietary phosphate within the gastrointestinal tract to prevent its absorption, thereby regulating serum phosphate levels. In the context of pharmaceutical research and development, this category provides essential reference standards, including the parent compound and its related impurities. These reference materials are critical for impurity profiling and method validation, allowing laboratories to accurately identify, quantify, and monitor potential structural analogues or degradation products. By utilizing these high-quality compounds, analytical chemists can maintain rigorous quality control standards, ensuring the consistency and regulatory compliance of pharmaceutical manufacturing processes during the development of phosphate-binding treatments.